Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer

Anticancer Research

Volumn 20, Issue 3 B, 2000, Pages 1959-1964

  Gadducci, Angiolo ^a   Iacconi, Pietro ^b   Fanucchi, Antonio ^b   Cosio, Stefania ^b   Teti, Giancarlo ^b   Genazzani, Andrea Riccardo ^b  

^a UNIVERSITY OF PISA   (Italy)

^b NONE

Author keywords

Cytoreduction; Ovarian cancer; Second look; Surgery

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; IFOSFAMIDE; PACLITAXEL;

ADVANCED CANCER; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; LAPAROTOMY; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; OVARY CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CISPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FEMALE; HUMANS; IFOSFAMIDE; LAPAROTOMY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; OVARIAN NEOPLASMS; OVARIECTOMY; PACLITAXEL; PERITONEAL NEOPLASMS; REOPERATION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0033869128     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bertelsen K, Hansen MK, Pedersen PH, Larsen G, Nyland M, Jacobsen M and Andersen JE: The prognostic and therapeutic value of second-look laparotomy in advanced ovarian cancer. Br J Obstet Gynaecol 95: 1231-1236, 1988.
2. Creasman WT: Second-look laparotomy in ovarian cancer. Gynecol Oncol 55: S122-S127, 1994.
3. Rubin SC, Hoskins WJ, Hakes TB, Markman M, Cain JM and Lewis JL Jr: Recurrence after negative second-look laparotomy for ovarian cancer: Analysis of risk factors. Am J Obstet Gynecol 159: 1094-1098, 1988.
4. Podratz KC, Malkasian GD Jr, Wieand HS, Cha SS, Lee RA, Stanhope CR and Williams TJ: Recurrent disease after negative second-look laparotomy in stage III and IV ovarian carcinoma. Gynecol Oncol 29: 274-282, 1988.
5. Lund B and Williamson P: Prognostic factors for outcome of and survival after second-look laparotomy in patients with advanced ovarian carcinoma. Obstet Gynecol 76: 617-622, 1990.
6. Potter ME, Hatch KD, Soong SJ, Partridge EE, Austin JM Jr and Shingleton HN: Second-look laparotomy and salvage therapy: A research modality only? Gynecol Oncol 44: 3-9, 1992.
7. Baker TR, Piver MS and Hempling RE: Long term survival by cytoreductive surgery to less than 1 cm, induction weekly cisplatin and monthly cisplatin, doxorubicin, and cyclophosphamide therapy in advanced ovarian adenocarcinoma. Cancer 74: 656-663, 1994.
8. Gadducci A, Sartori E, Maggino T, Zola P, Landoni F, Fanucchi A, Palai N, Alessi C, Ferrero AM, Cosio S and Cristofani R: Analysis of failures after negative second-look in patients with advanced ovarian cancer: An Italian multicenter study. Gynecol Oncol 68: 150-155, 1998.
9. Lippman SM, Alberts DS, Slymen DJ, Weinger S, Aristizahal SA, Luditch A, Davis JR and Surwit EA: Second-look laparotomy in epithelial ovarian carcinoma. Prognostic factors associated with survival duration. Cancer 61: 2571-2577, 1988.
10. Podczaski E, Manetta A, Kaminski P, Ricelli A, Larson J, DeGeest K and Mortel R: Survival of patients with ovarian epithelial carcinomas after second-look laparotomy. Gynecol Oncol 36: 43-47, 1990.
11. Bertelsen K: Tumor reduction surgery and long-term survival in advanced ovarian cancer: A DACOVA study. Gynecol Oncol 38: 203-209, 1990.
12. Dauplat J, Ferriere JP, Gorbinet M, Legros M, Chollet P, Giraud B and Plagne R: Second-look laparotomy in managing epithelial ovarian carcinoma. Cancer 57: 1624-1631, 1985.
13. Podratz KC, Schray MF, Wieand HS, Ecdmonson JH, Jefferies JA, Long HJ, Malkasian GD, Stanhope CR and Wilson TO: Evaluation of treatment and survival after positive second-look laparotomy. Gynecol Oncol 31: 9-24, 1988.
14. Hoskins WJ, Rubin SC, Dulaney E, Chapman D, Almadrones L, Saigo P, Markman M, Hakes T, Reichman B, Jones WB and Lewis JL Jr: Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinoma. Gynecol Oncol 34: 365-371, 1989.
15. Maggioni A, Colombo N, Parma G, Rossi R, Vecchione F, Cantu' MG and Bocciolone L: The role of secondary cytoreduction (SC) at the time of second look surgery in advanced ovarian carcinoma: Long-term follow-up. Int J Gynecol Cancer 7 (Suppl.2): 28, 079a (Abstract), 1997.
16. Raju KS, McKinna JA, Barker GH, Wiltshaw E and Jones JM: Second-look operations in the planned management of advanced ovarian carcinoma. Am J Obstet Gynecol 144: 650-654, 1982.
17. Hainsworth JD, Grosh WW, Burnett LS, Jones HW 3rd, Wolff SN and Greco FA: Advanced ovarian cancer: Long-term results of treatment with intensive cipslatin-based chemotherapy of brief duration. Ann Intern Med 108: 165-170, 1988.
18. Chambers SK, Chambers JT, Kohorn EI, Lawrence R and Schwartz PE: Evaluation of the role of second-look surgery in ovarian cancer. Obstet Gynecol 72: 404-408, 1988.
19. Luesley D, Lawton F, Blackledge G, Hilton C, Kelly K, Rollanson T, Wade-Evans T, Jordan J, Fielding J and Latief T et al: Failure of second-look laparotomy to influence survival in epithelial ovarian cancer. Lancet 2: 599-603, 1988.
20. Maggino T, Gadducci A, Romagnolo C, Fanucchi A and Fioretti P: times and sites of relapses after negative second look in advanced epithelial ovarian cancer. Eur J Surg Oncol 20: 146-150, 1994.
21. Gadducci A, Zola P, Landoni F, Maggino T, Sartori E, Bergamino T and Cristofani R: Serum half-life of CA 125 during early chemotherapy as an independent prognostic variable for patients with advanced epithelial ovarian cancer: Results of a multicentric Italian study. Gynecol Oncol 58: 42-48, 1995.
22. Podratz KC and Cliby WA: Second-look surgery in the management of epithelial ovarian carcinoma. Gynecol Oncol 55: S128-S133, 1994.
23. Morgan MA and Rubin SC: Secondary cytoreduction in epithelial ovarian cancer. Crit Rev Oncol Hematol 18: 1-8, 1995.
24. Berek JS, Hacker NF, Lagasse LD, Nieberg RK and Elashoff RM: Survival of patients following secondary cytoreductive surgery in ovarian cancer. Obstet Gynecol 61: 189-193, 1983.
25. Copeland LJ, Wharton JT, Rutledge FN, Gershenson DM, Seski JC and Herson J: Role of "third-look" laparotomy in the guidance of ovarian cancer treatment. Gynecol Oncol 15: 145-153, 1983.
26. Williams L, Brunetto VL, Yordan E, DiSaia PJ and Creasman WT: Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer: A Gynecologic Oncology Group Study. Gynecol Oncol 66: 171-178, 1997.
27. Howell SB, Zimm S, Markman M, Abramson IS, Clearly S, Lucas WE and Weiss RJ: Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy. J Clin Oncol 5: 1607-1612, 1987.
28. Heintz APM: Secondary cytoreductive surgery: Who benefits from it? Gynecol Oncol 66: 169-170, 1997.